Bio-Techne (TECH) EBT (2009 - 2026)

Bio-Techne's EBT history runs 18 years deep, the most recent figure standing at $71.2 million for Q1 2026.

• In Q1 2026, EBT rose 86.09% year-over-year to $71.2 million; the TTM figure through Mar 2026 stood at $60.3 million (down 60.34% YoY), while the FY2025 annual figure was $11.6 million, down 93.34% from the prior year.
• EBT for Q1 2026 stood at $71.2 million, up from $50.8 million in the prior quarter.
• The five-year high for EBT was $103.7 million in Q3 2022, with the low at -$109.7 million in Q2 2025.
• The 5-year median for EBT is $50.8 million (2025), against an average of $49.6 million.
• The sharpest annual moves came in 2022 and 2025: EBT surged 1011.37% in 2022, then plunged 456.34% in 2025.
• Bio-Techne's EBT stood at $66.4 million in 2022, then plunged by 49.74% to $33.4 million in 2023, then climbed by 28.42% to $42.9 million in 2024, then increased by 18.44% to $50.8 million in 2025, then surged by 40.25% to $71.2 million in 2026.
• Business Quant data shows TECH's EBT at $71.2 million in Q1 2026, $50.8 million in Q4 2025, and $48.0 million in Q3 2025.